Natural Killer Cell Dynamics at the Maternal-Fetal Interface

Natural killer (NK) cells constitute the predominant lymphoid population within the decidua during early pregnancy, orchestrating a finely balanced programme of immune regulation, tissue remodelling and host defence. Unlike their peripheral counterparts, decidual NK (dNK) cells exhibit specialised phenotypes and reduced cytotoxicity, releasing cytokines and growth factors that promote extravillous trophoblast invasion and spiral artery remodelling. Distinct subsets of uterine tissue-resident NK (trNK) cells emerge through differentiation pathways controlled by local signals, ensuring both vascular adaptation and protection against infection. Interactions between inhibitory and activating receptors on NK cells and polymorphic major histocompatibility complex (MHC) class I molecules expressed by maternal and fetal tissues shape NK education and functional competence. Dysregulation of these dynamic processes has been linked to pregnancy complications such as pre-eclampsia, recurrent pregnancy loss and fetal growth restriction. Advances in single-cell transcriptomics, organoid co-culture systems and humanised animal models have deepened understanding of NK cell heterogeneity, memory-like features and the molecular circuits that harness their functions to support gestation while safeguarding both mother and fetus.

Research from Nature Portfolio

Recent work has defined the IL-21R–STAT3 signalling axis as a key driver of trNK cell differentiation in the pregnant uterus, revealing discrete developmental stages with specialised functions in spiral artery remodelling and controlled apoptotic programmes that limit tissue damage. Foundational studies have demonstrated that maternal MHC class I alleles selectively educate uterine NK cells, with an excess of inhibitory signals impairing arterial adaptation and leading to reduced fetal growth independently of parental origin. Investigations in models of fetal alloimmune thrombocytopenia have shown that aberrant activation of uNK cells causes trophoblast apoptosis, vascular pathology and miscarriage; targeted blockade of activating receptors or NK depletion restores normal placentation and prevents pregnancy loss.

Natural Killer Cell Dynamics at the Maternal-Fetal Interface publication trend

The graph below shows the total number of articles in natural killer cell dynamics at the maternal-fetal interface across all publications each year (not limited to Nature Index journals).

Technical terms

Decidua: The specialised uterine lining during pregnancy where maternal–fetal interactions occur.

Extravillous trophoblast (EVT): Invasive placental cells that remodel maternal blood vessels.

Spiral artery remodelling: Transformation of maternal uterine arteries to increase blood supply to the placenta.

Tissue-resident NK (trNK) cell: A subset of NK cell permanently residing in uterine tissue with distinct differentiation stages.

Cytokine: A signalling protein released by immune cells to modulate cell growth, differentiation and inflammation.

Killer immunoglobulin-like receptor (KIR): A family of NK cell receptors that recognise MHC class I molecules and regulate NK cell activation.

References

1. Natural Killer Cells in the Human Uterine Mucosa. Annual Review of Immunology (2023).
2. Human uterine natural killer cells regulate differentiation of extravillous trophoblast early in pregnancy. Cell Stem Cell (2024).
3. IL-21R-STAT3 signalling initiates a differentiation program in uterine tissue-resident NK cells to support pregnancy. Nature Communications (2023).
4. Human CD56+CD39+ dNK cells support fetal survival through controlling trophoblastic cell fate: immune mechanisms of recurrent early pregnancy loss. National Science Review (2024).
5. Cytokine modulation and immunoregulation of uterine NK cells in pregnancy disorders. Cytokine & Growth Factor Reviews (2024).
6. MHC-dependent inhibition of uterine NK cells impedes fetal growth and decidual vascular remodelling. Nature Communications (2014).
7. Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia. Nature Communications (2017).